Pneumatocele in a traumatic ruptured lacrimal sac mucocele

Casselman, J; Pt, Peene; Coppens, Filip; Vanneste, F.

doi:10.1055/s-2008-1046987

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These sounds were likely produced by turbulent airflow in a small diameter canal at high pressure. Both the patients had no tearing symp-positive airway pressure, sleep apnea, and punctal plug insertion [3][4][5][6].…”

Section: Report Of the Casesmentioning

confidence: 99%

Retrograde Air Flow through the Lacrimal Drainage System with Valsalva Maneuver

Swati¹,

Javed²,

Miel³

et al. 2020

J Otolaryngol Rhinol

View full text Add to dashboard Cite

show abstract

Section: Report Of the Casesmentioning

confidence: 99%

Retrograde Air Flow through the Lacrimal Drainage System with Valsalva Maneuver

Swati¹,

Javed²,

Miel³

et al. 2020

J Otolaryngol Rhinol

View full text Add to dashboard Cite

show abstract

Lacrimal Sac Pneumatocele Following Blunt Nasal Trauma

Das

Ali

Bansal

et al. 2017

Ophthalmic Plastic &Amp; Reconstructive Surgery

View full text Add to dashboard Cite

Pneumatocele of the lacrimal sac is an uncommon entity and has been rarely reported in literature. The valvular function of the Hasner's valve at the lower end of nasolacrimal duct is presumed to prevent the retrograde reflux of air into the lacrimal sac with increased intranasal pressure as in valsalva maneuver. Loss of this valvular function as noted with persistent positive airway pressure ventilation can cause retrograde air reflux into lacrimal sac. The authors report a case of lacrimal sac pneumatocele which developed following blunt nasal trauma involving the bony nasolacrimal duct.

show abstract

Impact of new treatment options for hepatitis C virus infection in liver transplantation

Righi¹

2015

WJG

View full text Add to dashboard Cite

Liver transplant candidates and recipients with hepatitis C virus (HCV)-related liver disease greatly benefit from an effective antiviral therapy. The achievement of a sustained virological response before transplantation can prevent the recurrence of post-transplant HCV disease that occurs universally and correlates with enhanced progression to graft cirrhosis. Previous standard-of-care regimens (e.g., pegylated-interferon plus ribavirin with or without first generation protease inhibitors, boceprevir and telaprevir) displayed suboptimal results and poor tolerance in liver transplant recipients. A new class of potent direct-acting antiviral agents (DAA) characterized by all-oral regimens with minimal side effects has been approved and included in the recent guidelines for the treatment of liver transplant recipients with recurrent HCV disease. Association of sofosbuvir with ribavirin and/or ledipasvir is recommended in liver transplant recipients and patients with decompensated cirrhosis. Other regimens include simeprevir, daclatasvir, and combination of other DAA. Possible interactions should be monitored, especially in coinfected human immunodeficiency virus/HCV patients receiving antiretrovirals.

show abstract

Pneumatocele in a traumatic ruptured lacrimal sac mucocele

Cited by 3 publications

References 0 publications

Retrograde Air Flow through the Lacrimal Drainage System with Valsalva Maneuver

Retrograde Air Flow through the Lacrimal Drainage System with Valsalva Maneuver

Lacrimal Sac Pneumatocele Following Blunt Nasal Trauma

Impact of new treatment options for hepatitis C virus infection in liver transplantation

Contact Info

Product

Resources

About